Harrow Enters 340B Contract With Apexus For Key Products
09 Jul 2024 //
BUSINESSWIRE
Harrow Announces Transitional Pass-Through Reimbursement Status for IHEEZO
13 Mar 2023 //
BUSINESSWIRE
Harrow Announces Permanent, Product-Specific J-Code (J2403) for IHEEZO
02 Feb 2023 //
BUSINESSWIRE
Harrow Announces U.S. FDA Approval of IHEEZO
27 Sep 2022 //
BIOSPACE
Harrow Announces U.S. FDA Approval of IHEEZO
27 Sep 2022 //
BUSINESSWIRE